Drugs / JEVAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01408537 | May 2010 → Oct 2012 | Japanese encephalitis | Mahidol University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JEVAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01408537 ↗ |
| Modality | Vaccine | “inactivated Vero cell derived JE vaccine (Beijing P-3 strain)” NCT01408537 ↗ |
| Route | Subcutaneous | “JEVAC subcutaneously on Day 0” NCT01408537 ↗ |